Accurate diagnosis and staging are essential for the optimal management of cancer
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …

Positron Emission Tomography (PET) is a significant advance in cancer imaging with great
potential for optimizing radiation therapy (RT) treatment planning and thereby improving …

Molecular imaging, in particular, PET, has brought an additional dimension to management
for patients with cancer. 18 F-FDG, which is the most widely available tracer, has been …

Partial-volume errors (PVEs) in PET can cause incorrect estimation of radiopharmaceutical
uptake in small tumors. An iterative postreconstruction method was evaluated that corrects …

Purpose: To clarify the radiotherapy clinical target volume (CTV) margin needed for
esophageal squamous-cell carcinoma (SCC) and gastroesophageal junction (GEJ) …

The delineation of tumors and their surrounding organs at risk is a critical step of the
treatment planning for radiation therapy. Besides computer tomography (CT), other imaging …

Highlights•The role of FDG-PET/CT and MRI with diffusion-weighted imaging in the
management of oesophageal cancer is expanding.•Their value in staging, response …

Purpose: FDG-PET/CT has proven to be useful in the staging process of esophageal
tumours. This review analysed the role of FDG-PET/CT in tumour delineation and …

Accurate, robust and reproducible delineation of tumour in Positron Emission Tomography
(PET) is essential for diagnosis, treatment planning and response assessment. Since …

Purpose: The aim of this study was to investigate the impact of a hybrid fluorodeoxyglucose
positron-emission tomography/computed tomography (FDG-PET/CT) scanner in …